Table of Contents Author Guidelines Submit a Manuscript
Volume 2011, Article ID 160369, 5 pages
Case Report

Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature

1Department of Medicine, Akron General Medical Center, 400 Wabash Avenue, Akron, OH 44307, USA
2Department of Medicine, Northeastern Ohio Universities, College of Medicine and Pharmacy, Rootstown, OH 44272, USA
3Department of Pathology, Akron General Medical Center, 400 Wabash Avenue, Akron, OH 44307, USA

Received 18 October 2010; Accepted 27 February 2011

Academic Editor: Marcus Schlemmer

Copyright © 2011 Jocelyn T. De Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Angiosarcoma (AS) is a rare and aggressive vascular neoplasm with very poor prognosis. Patients with extensive cutaneous AS who are not surgical candidates have very limited options since there is no standard treatment. Treatment options include radiation, chemotherapy, and angiogenesis inhibitor with varying success rates. Here, we report a case an 88 year old patient with extensive scalp angiosarcoma having biopsy proven remission with bevacizumab and radiotherapy without undergoing surgery.